BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) reported fourth-quarter adjusted EPS of 92 cents, up from 49 cents reported a year ago, beating the consensus of 53 cents. The company reported sales of $747 ...

BioMarin's gene therapy pipeline has had setbacks, including a three-year delay in US approval of Roctavian and stalled development of PKU gene therapy BMN 307 as the Food and Drug Administration ...

When BMRN reports fourth-quarter earnings, investors will likely focus on the sales performance of its dwarfism drug Voxzogo.

Q4 2024 Earnings Call Transcript February 19, 2025 BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.64, expectations were $0.54. Operator: Ladies and gentlemen, thank you ...

BioMarin Pharmaceutical Inc. ( NASDAQ: BMRN) Q4 2024 Earnings Conference Call February 19, 2025 4:30 PM ET Traci McCarty - Head of IR Alexander Hardy - President and CEO Brian Mueller - EVP and CFO ...

Parents Hailey and Juan Lucero said they knew what to expect having their daughter, Adaliyah as a preemie, but what they did ...

The worlds that I’m creating with the detective novels and with 'Learwife' are different. They’re going to do very different ...

Strong Execution and Operational Transformation in 2024 Delivered Record Full Year Results and Provides Momentum for Double-Digit Revenue and Prof ...

Peggy Noonan rightly laments the inability of Democrats to say why or how their party committed itself to such unpopular positions (“Government Keeps Going Too Far,” Declarations, Feb. 8).

Shamrock Rovers recorded another famous European victory against Norwegian side Molde, as 16-year-old Michael Noonan created history with a debut goal. The Hoops secured the advantage going into ...

Michael Noonan hit the back of the net as Rovers beat Molde 1-0 in Norway last night, aged 16 years and 197 days. It means that he is also the second youngest goalscorer in European club competition.